Samsara BioCapital, L.P. 13D and 13G filings for Kalaris Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-25 7:40 pm Purchase | 2025-03-18 | 13D | Kalaris Therapeutics Inc KLRS | Samsara BioCapital, L.P. | 11,448,081 61.200% | 11,448,081 (New Position) | Filing |